Recent Security Class Actions

Cassava Sciences Inc. Common Stock (NASDAQ: SAVA)

Company Name:Cassava Sciences Inc. Common Stock
Stock Symbol:NASDAQ: SAVA
Class Period Start:02/07/2024
Class Period End (inclusive):11/24/2024
Filing Deadline:02/10/2025

The Complaint alleges Defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true capabilities of Cassava’s drugs; notably, that Company simply did not have a drug that was capable of abating the progression of Alzheimer’s Disease.